Good News! No - GREAT News! Now that the US Diabetets experts are calling for individualized drug therapy for type 2 persons with diabetes and the American Diabetes Association is recommending individualized carbohydrate levels, maybe it will be easier for those with type 2 to finally develop the levels and goals that will for work for them as individuals.
Not that this is a cure-all, but these changes should allow for more meaningful dialogs between medical professionals and patients. It will take some time for all levels of the medical profession to learn and adapt to these new recommendations, but at least the patients will soon know that the “one size fits all” philosophy is, for now, at least in the past.
No comments:
Post a Comment